Aberdeen Group Portfolio holdings
AUM
$63.2B
1-Year Est. Return
27.07%
1 Year Est. Return
+27.07%
AUM
$58.8B
AUM Growth
+$7.51B
(+15%)
Holding
979
Top Buys
| 1 | +$158M | |
| 2 | +$156M | |
| 3 | +$152M | |
| 4 |
Microsoft
MSFT
|
+$123M |
| 5 |
Meta Platforms (Facebook)
META
|
+$85.2M |
Top Sells
| 1 | +$68.7M | |
| 2 | +$60.5M | |
| 3 | +$47M | |
| 4 |
Canadian Pacific Kansas City
CP
|
+$36.6M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$30.9M |
Sector Composition
| 1 | Technology | 32.3% |
| 2 | Healthcare | 12.75% |
| 3 | Consumer Discretionary | 11.56% |
| 4 | Financials | 10.82% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Gen Digital
GEN
$16.7B
| $13.5M | 0.02% |
461,713
+13,827
|
|
||
527
Diamondback Energy
FANG
$41.9B
| $13.5M | 0.02% |
98,547
+4,017
|
|
||
528
Immunovant
IMVT
$4.09B
| $13.5M | 0.02% |
844,705
+25,228
|
|
||
529
Ameren
AEE
$28.6B
| $13.5M | 0.02% |
140,640
+11,658
|
|
||
530
Idacorp
IDA
$7.06B
| $13.4M | 0.02% |
115,978
+24,762
|
|
||
531
Medpace
MEDP
$16.8B
| $13.4M | 0.02% |
42,556
-21,553
|
|
||
532
NewAmsterdam Pharma
NAMS
$4.34B
| $13.3M | 0.02% |
735,032
+358,169
|
|
||
533
C.H. Robinson
CHRW
$18.1B
| $13.3M | 0.02% |
138,688
+24,587
|
|
||
534
Travere Therapeutics
TVTX
$3.26B
| $13.3M | 0.02% |
896,594
+416,225
|
|
||
535
iShares MSCI Taiwan ETF
EWT
$6.79B
| $13.2M | 0.02% |
230,973
+89,367
|
|
||
536
Baxter International
BAX
$9.61B
| $13.2M | 0.02% |
437,321
+53,257
|
|
||
537
MongoDB
MDB
$29.7B
| $13.1M | 0.02% |
62,570
+2,503
|
|
||
538
Dow Inc
DOW
$15.8B
| $13.1M | 0.02% |
488,920
+20,126
|
|
||
539
DTE Energy
DTE
$29.1B
| $12.9M | 0.02% |
97,536
+8,550
|
|
||
540
Kilroy Realty
KRC
$5B
| $12.8M | 0.02% |
372,167
+336,953
|
|
||
541
ICICI Bank
IBN
$109B
| $12.7M | 0.02% |
378,223
+67,937
|
|
||
542
Cidara Therapeutics
CDTX
$3.37B
| $12.7M | 0.02% |
259,916
+139,037
|
|
||
543
Halliburton
HAL
$22.7B
| $12.6M | 0.02% |
613,025
+21,736
|
|
||
544
Denali Therapeutics
DNLI
$2.57B
| $12.6M | 0.02% |
902,751
+142,936
|
|
||
545
GeneDx Holdings
WGS
$3.94B
| $12.6M | 0.02% |
+136,732
|
|
||
546
NiSource
NI
$20.7B
| $12.5M | 0.02% |
310,284
+48,533
|
|
||
547
Magnolia Oil & Gas
MGY
$4.16B
| $12.3M | 0.02% |
546,267
-74,464
|
|
||
548
Markel Group
MKL
$26.4B
| $12.3M | 0.02% |
6,135
+326
|
|
||
549
Aaon
AAON
$8.33B
| $12.2M | 0.02% |
165,897
+136,288
|
|
||
550
Rio Tinto
RIO
$116B
| $12.2M | 0.02% |
208,700
+6,600
|
|